首页> 美国卫生研究院文献>Open Forum Infectious Diseases >Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

【2h】

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

机译：造血细胞移植受者的粘膜粘剂和新抗真菌剂时代血液恶性肿瘤患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The survival benefit of combination antifungal therapy for invasive mucormycosis (IM) in patients with hematologic malignancy (HM) and hematopoietic cell transplant (HCT) is not well defined.

机译：血液学恶性肿瘤（HM）和造血细胞移植（HCT）患者对侵袭性粘膜（IM）组合抗真菌治疗的生存效益并不明确。

著录项

期刊名称 Open Forum Infectious Diseases
作者
Matthew A Miller; Kyle C Molina; Jonathan A Gutman; Sias Scherger; Jessica M Lum; Sherif B Mossad; Mary Burgess; Matthew P Cheng; Sally T Chuang; Samantha E Jacobs; Dante P Melendez; Dimpy P Shah; Andrea Zimmer; M Rizwan Sohail; Sadia Syed; Randall C Walker; Eric M Poeschla; Maheen Z Abidi;
展开▼
作者单位

展开▼
年(卷),期 2021(8),2
年度 2021
页码 ofaa646
总页数 6
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词
Mucormycosis; Hematopoeitic cell Transplant; Isavuconazole;

机译：粘液菌;血液缺细胞移植;异戊酰唑;

相似文献

外文文献
中文文献
专利

1. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan [J] . Ko Bor-Sheng, Chen Wei-Ting, Kung Hsiang-Chi, Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi . 2018,第3期

机译：2016年血液恶性肿瘤患者抗真菌剂或台湾造血干细胞移植受体的指南策略
2. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients. [J] . Almyroudis NG, Segal BH Expert review of anti-infective therapy . 2010,第12期

机译：血液系统恶性肿瘤和造血干细胞移植受者的抗真菌预防和治疗。
3. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. [J] . Leather HL, Wingard JR Blood reviews . 2006,第5期

机译：造血干细胞移植受者和血液系统恶性肿瘤患者抗真菌治疗的新策略。
4. A clinical trial of prophylactic antifungal therapy in patients undergoing hematopoietic stem cell transplantation [C] . Zhou Qi, Lou Fangding, Zhang Bolong Proceedings of the Fourth China-Jpan international congress of mycology . 1998

机译：造血干细胞移植患者预防性抗真菌治疗的临床试验
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis 2001 to 2009 [O] . Sarah P. Hammond, Lindsey R. Baden, Francisco M. Marty 2011

机译：2001年至2009年毛霉菌病血液恶性肿瘤和造血干细胞移植患者的死亡率
7. Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents [O] . Matthew A Miller, Kyle C Molina, Jonathan A Gutman, 2020

机译：造血细胞移植受者的粘膜粘剂和新抗真菌剂时代血液恶性肿瘤患者

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

摘要

著录项

相似文献

相关主题

期刊订阅